Projects per year
Abstract
Neuroendocrine prostate cancer is an aggressive disease subtype associated with poor patient outcome. Fernandes et al. demonstrate that a microRNA, miR-194, promotes the emergence of neuroendocrine features in prostate cancer cells by targeting genes that regulate epithelial-neuroendocrine plasticity. Inhibiting miR-194 suppresses the growth of neuroendocrine prostate cancer models.
| Original language | English |
|---|---|
| Article number | 108585 |
| Number of pages | 23 |
| Journal | Cell Reports |
| Volume | 34 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 5 Jan 2021 |
Keywords
- FOXA1
- lineage plasticity
- microRNA
- miR-194
- neuroendocrine prostate cancer
- post-transcriptional gene regulation
- prostate cancer
- transdifferentiation
Projects
- 4 Finished
-
New combination therapies for castration-resistant prostate cancer
Lawrence, M. (Primary Chief Investigator (PCI)), Risbridger, G. (Associate Investigator (AI)), Azad, A. (Associate Investigator (AI)) & Taylor, R. (Associate Investigator (AI))
15/02/19 → 14/02/23
Project: Research
-
A novel strategy for targeting castrate-resistant prostate cancer
Risbridger, G. (Primary Chief Investigator (PCI)), Tilley, W. D. (Chief Investigator (CI)), Furic, L. (Chief Investigator (CI)), Sandhu, S. (Chief Investigator (CI)), Azad, A. (Chief Investigator (CI)), Selth, L. A. (Chief Investigator (CI)) & Lawrence, M. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/18 → 31/12/21
Project: Research
-
Dual Targeting of the Androgen Receptor for Effective and Durable Control of Lethal Prostate Cancer
Tilley, W. D. (Primary Chief Investigator (PCI)), Risbridger, G. (Chief Investigator (CI)), Raj, G. V. (Chief Investigator (CI)), Selth, L. A. (Chief Investigator (CI)), Taylor, R. (Chief Investigator (CI)) & Joshua, A. M. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/17 → 31/12/20
Project: Research